CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Planned sale Director sold 10,200 shares at $0.67 ($6,834)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,359 shares at $0.69 ($3,008)
- 144 Insider Sale of Securities
- 8-K Event Agreement ended
- 4 Open-market sale Chief R&D Officer sold 9,703 shares at $0.78 ($7,568)
- 4 Open-market sale Chief Legal Officer sold 7,221 shares at $0.78 ($5,632)
- 4 Open-market sale President & CEO sold 19,998 shares at $0.78 ($15,598)
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale Director sold 30,000 shares at $0.57 ($17,100)
Page 14 of 100 · 1,982 filings